Showing results (31-40 of 265) with videos related to

Sort By:
Pageof 27
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 30, 2006
In vitro studies on gemcitabine combinations with other antiblasticsE Giovannetti, R Danesi, V Mey, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
3'-Deamino-3'-(2-methoxy-4-morpholinyl)-doxorubicin (FCE 23762): a new anthracycline derivative with enhanced cytotoxicity and reduced cardiotoxicityR Danesi, C Agen, M Grandi, et al.
Trends in Pharmacological Sciences|August 2, 2001
Pharmacogenetic determinants of anti-cancer drug activity and toxicityR Danesi, F De Braud, S Fogli, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Reducing doxorubicin cardiotoxicity in the rat using deferred treatment with ADR-529C Agen, N Bernardini, R Danesi, et al.
Drugs Under Experimental and Clinical Research|January 1, 1988
A pharmacokinetic study of clofoctol in human plasma and lung tissue by using a microbiological assayR Danesi, M Gasperini, S Senesi, et al.
Molecular Human Reproduction|July 27, 2001
In-vitro evidence of autocrine secretion of vascular endothelial growth factor by endothelial cells from human placental blood vesselsG Bocci, A Fasciani, R Danesi, et al.
Molecular Pharmacology|June 1, 1996
Phenylacetate inhibits protein isoprenylation and growth of the androgen-independent LNCaP prostate cancer cells transfected with the T24 Ha-ras oncogeneR Danesi, D Nardini, F Basolo, et al.
Oncology|January 1, 1991
Anthracycline cardiotoxicity: in vivo and in vitro effects on biochemical parameters and heart ultrastructure of the ratG Cini Neri, B Neri, M Bandinelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2002
Gemcitabine, epirubicin and paclitaxel: pharmacokinetic and pharmacodynamic interactions in advanced breast cancerS Fogli, R Danesi, A Gennari, et al.
Cancer Chemotherapy and Pharmacology|January 29, 1999
Metabolism of 6-mercaptopurine in the erythrocytes, liver, and kidney of rats during multiple-dose regimensF Innocenti, R Danesi, G Bocci, et al.
Pageof 27